PMID- 37037306 OWN - NLM STAT- MEDLINE DCOM- 20230613 LR - 20240506 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 299 IP - 5 DP - 2023 May TI - PTEN-induced kinase PINK1 supports colorectal cancer growth by regulating the labile iron pool. PG - 104691 LID - S0021-9258(23)00333-2 [pii] LID - 10.1016/j.jbc.2023.104691 [doi] LID - 104691 AB - Mitophagy is a cargo-specific autophagic process that recycles damaged mitochondria to promote mitochondrial turnover. PTEN-induced putative kinase 1 (PINK1) mediates the canonical mitophagic pathway. However, the role of PINK1 in diseases where mitophagy has been purported to play a role, such as colorectal cancer, is unclear. Our results here demonstrate that higher PINK1 expression is positively correlated with decreased colon cancer survival, and mitophagy is required for colon cancer growth. We show that doxycycline-inducible knockdown (KD) of PINK1 in a panel of colon cancer cell lines inhibited proliferation, whereas disruption of other mitophagy receptors did not impact cell growth. We observed that PINK KD led to a decrease in mitochondrial respiration, membrane hyperpolarization, accumulation of mitochondrial DNA, and depletion of antioxidant glutathione. In addition, mitochondria are important hubs for the utilization of iron and synthesizing iron-dependent cofactors such as heme and iron sulfur clusters. We observed an increase in the iron storage protein ferritin and a decreased labile iron pool in the PINK1 KD cells, but total cellular iron or markers of iron starvation/overload were not affected. Finally, cellular iron storage and the labile iron pool are maintained via autophagic degradation of ferritin (ferritinophagy). We found overexpressing nuclear receptor coactivator 4, a key adaptor for ferritinophagy, rescued cell growth and the labile iron pool in PINK1 KD cells. These results indicate that PINK1 integrates mitophagy and ferritinophagy to regulate intracellular iron availability and is essential for maintaining intracellular iron homeostasis to support survival and growth in colorectal cancer cells. CI - Copyright (c) 2023 The Authors. Published by Elsevier Inc. All rights reserved. FAU - Chen, Brandon AU - Chen B AD - Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA. FAU - Das, Nupur K AU - Das NK AD - Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA. FAU - Talukder, Indrani AU - Talukder I AD - Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA. FAU - Singhal, Rashi AU - Singhal R AD - Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA. FAU - Castillo, Cristina AU - Castillo C AD - Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA. FAU - Andren, Anthony AU - Andren A AD - Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA. FAU - Mancias, Joseph D AU - Mancias JD AD - Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. FAU - Lyssiotis, Costas A AU - Lyssiotis CA AD - Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA; University of Michigan Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: clyssiot@med.umich.edu. FAU - Shah, Yatrik M AU - Shah YM AD - Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA; University of Michigan Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: shahy@umich.edu. LA - eng GR - R01 CA148828/CA/NCI NIH HHS/United States GR - R01 DK095201/DK/NIDDK NIH HHS/United States GR - T32 GM145470/GM/NIGMS NIH HHS/United States GR - P30 DK034933/DK/NIDDK NIH HHS/United States GR - R01 CA244931/CA/NCI NIH HHS/United States GR - R01 DK124384/DK/NIDDK NIH HHS/United States GR - P30 CA046592/CA/NCI NIH HHS/United States GR - R01 CA248160/CA/NCI NIH HHS/United States GR - R01 CA245546/CA/NCI NIH HHS/United States GR - R37 CA237421/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20230408 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 9007-73-2 (Ferritins) RN - E1UOL152H7 (Iron) RN - EC 2.7.- (Protein Kinases) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) RN - EC 2.7.11.1 (PTEN-induced putative kinase) SB - IM MH - Humans MH - *Colonic Neoplasms/genetics/pathology MH - *Colorectal Neoplasms/genetics/pathology MH - Ferritins MH - Iron/metabolism MH - *Protein Kinases/genetics/metabolism MH - Ubiquitin-Protein Ligases/metabolism MH - *Mitophagy PMC - PMC10196865 OTO - NOTNLM OT - colon cancer OT - ferritinophagy OT - iron OT - mitochondria OT - mitophagy COIS- Conflict of interest C. A. L. has received consulting fees from Astellas Pharmaceuticals, Odyssey Therapeutics, and T-Knife Therapeutics and is an inventor on patents pertaining to Kras-regulated metabolic pathways, redox control pathways in pancreatic cancer, and targeting the GOT1-pathway as a therapeutic approach (US Patent No: 2015126580-A1, 05/07/2015; US Patent No: 20190136238, 05/09/2019; International Patent No: WO2013177426-A2, 04/23/2015). J. D. M. reports a patent for the modulation of NCOA4-mediated autophagic targeting of ferritin (PCT/US2015/023142) issued. EDAT- 2023/04/11 06:00 MHDA- 2023/05/29 06:42 PMCR- 2023/04/08 CRDT- 2023/04/10 19:21 PHST- 2022/10/01 00:00 [received] PHST- 2023/04/01 00:00 [revised] PHST- 2023/04/03 00:00 [accepted] PHST- 2023/05/29 06:42 [medline] PHST- 2023/04/11 06:00 [pubmed] PHST- 2023/04/10 19:21 [entrez] PHST- 2023/04/08 00:00 [pmc-release] AID - S0021-9258(23)00333-2 [pii] AID - 104691 [pii] AID - 10.1016/j.jbc.2023.104691 [doi] PST - ppublish SO - J Biol Chem. 2023 May;299(5):104691. doi: 10.1016/j.jbc.2023.104691. Epub 2023 Apr 8.